Zaxaglit 5mg Tablet contains saxagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used in the treatment of type 2 diabetes in adults. Zaxaglit 5mg Tablet is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It is the first-line therapy for patients with type 2 diabetes that restores the body's response to insulin. Insulin is the hormone that controls sugar levels in your blood. People with type 2 diabetes either do not produce enough insulin, or the insulin produced is unable to perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes, so it is also known as adult-onset diabetes.

Zaxaglit 5mg Tablet works by blocking the action of DPP-4 (an enzyme which destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps to produce more insulin only when required and reduces blood sugar levels produced by the liver when not needed. Zaxaglit 5mg Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.

Zaxaglit 5mg Tablet should be taken with food or an empty stomach. However, it should be taken at the same time of the day each time for best results. For better advice, your doctor will decide what dose should be taken, and it can change timely depending upon your condition. The most common side effects of Zaxaglit 5mg Tablet are hypoglycemia (low blood glucose levels), upper respiratory tract infection, nasopharyngitis (infection of nose and throat with common cold) and headache.

Prolonged intake of Zaxaglit 5mg Tablet may cause acute pancreatitis (swollen pancreas), and critical kidney problem. Increased risk of hypoglycemia (low blood sugar level) can occur when Zaxaglit 5mg Tablet is added to other anti-diabetic agents or insulin therapy. In this case, your doctor may adjust the dose of Zaxaglit 5mg Tablet. Severe allergic reactions might occur in some patients taking Zaxaglit 5mg Tablet, like anaphylaxis, angioedema (swelling under the skin), and exfoliative skin conditions, including Stevens-Johnson syndrome. Safety and efficacy of Zaxaglit 5mg Tablet in children under 18 years have not been established, so it should not be given to them. Patients taking digoxin (a heart medicine) with Zaxaglit 5mg Tablet should be closely monitored as severe drug interaction has been observed.

Zaxaglit 5mg Tablet works by blocking the action of DPP-4 (an enzyme which destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps to produce more insulin only when required and reduces blood sugar levels produced by the liver when not needed. Thus, Zaxaglit 5mg Tablet plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer and delayed wound healing.

Zaxaglit 5mg Tablet works by blocking the action of DPP-4 (an enzyme which destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps to produce more insulin only when required and reduces blood sugar levels produced by the liver when not needed.

Increased risk of hypoglycemia (low blood sugar level) can occur when Zaxaglit 5mg Tablet is added to other anti-diabetic agents or insulin therapy. In this case, your doctor may adjust the dose of Zaxaglit 5mg Tablet. Prolonged intake of Zaxaglit 5mg Tablet may cause acute pancreatitis (swollen pancreas) and critical kidney problems. Severe allergic reactions might occur in some patients taking Zaxaglit 5mg Tablet, like anaphylaxis, angioedema (swelling under the skin), and exfoliative skin conditions, including Stevens-Johnson syndrome. Safety and efficacy of Zaxaglit 5mg Tablet in children under 18 years have not been established, so it should not be given to them. Patients taking digoxin (a heart medicine) with Zaxaglit 5mg Tablet should be closely monitored as severe drug interaction has been observed.